A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: A systematic review and Meta-analysis
[report]
2021
unpublished
Review question / Objective: We conducted this meta-analysis to explore the efficacy and safety of Tyrosine kinase inhibitors (TKIs) compared with non-TKIs regimens in HER-2 positive breast cancer with brain metastases. Condition being studied: The survival of breast cancer brain metastasis (BCBM) patients is extremely poor. The cornerstone INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols
doi:10.37766/inplasy2021.7.0064
fatcat:wdzppmlhkbfntnqkkhrznfwbsu